Litcius/Paper detail

Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study

Choong‐kun Lee, Jii Bum Lee, Se Jin Park, Jingmin Che, Woo Sun Kwon, Hyo Song Kim, Minkyu Jung, Seulkee Lee, Sook Ryun Park, Dong‐Hoe Koo, Hyun Woo Lee, Woo Kyun Bae, Hei‐Cheul Jeung, In Gyu Hwang, Hyunki Kim, Chung Mo Nam, Hyun Cheol Chung, Sun Young Rha

2023Gastric Cancer15 citationsDOIOpen Access PDF

Topics & Concepts

MedicineNivolumabInternal medicineNeutropeniaClinical endpointOncologyBiomarkerResponse Evaluation Criteria in Solid TumorsPhases of clinical researchCancerPaclitaxelLeukopeniaAdverse effectGastroenterologyClinical trialImmunotherapyChemotherapyBiochemistryChemistryCancer Immunotherapy and BiomarkersGastric Cancer Management and OutcomesHelicobacter pylori-related gastroenterology studies
Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study | Litcius